The HIF1α inhibitor TX-2098 similarly reduced expression of ALDOA and vascular endothelial growth factor (VEGF) in a xenograft model of pancreatic cancer (Miyake et al., 2012). Here, VEGFA is linked to pancreatic neoplasm.